| Literature DB >> 23166845 |
Linda O'Connor1, Catherine Plichart, Ayo Cheong Sang, Corey L Brelsfoard, Hervé C Bossin, Stephen L Dobson.
Abstract
BACKGROUND: Lymphatic filariasis (LF) is a globally significant disease, with 1.3 billion persons in 83 countries at risk. A coordinated effort of administering annual macrofilaricidal prophylactics to the entire at-risk population has succeeded in impacting and eliminating LF transmission in multiple regions. However, some areas in the South Pacific are predicted to persist as transmission sites, due in part to the biology of the mosquito vector, which has led to a call for additional tools to augment drug treatments. Autocidal strategies against mosquitoes are resurging in the effort against invasive mosquitoes and vector borne disease, with examples that include field trials of genetically modified mosquitoes and Wolbachia population replacement. However, critical questions must be addressed in anticipation of full field trials, including assessments of field competitiveness of transfected males and the risk of unintended population replacement. METHODOLOGY/PRINCIPALEntities:
Mesh:
Year: 2012 PMID: 23166845 PMCID: PMC3499408 DOI: 10.1371/journal.pntd.0001797
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Egg hatch resulting from intra- and inter-specific crosses.
| Egg Number | Percent | ||
| Unhatch | Hatch | Hatch | |
|
| |||
|
| 10,115 | 1 | 0.010% |
|
| 15,496 | 2 | 0.013% |
|
| |||
|
| 190 | 273 | 59.0% |
|
| 5 | 91 | 94.8% |
|
| 2 | 598 | 99.7% |
|
| 57 | 163 | 74.1% |
Interspecific crosses consist of CP males combined with virgin female.
A. polynesiensis, A. aegypti and A. albopictus.
Figure 1A. polynesiensis population dynamics.
Collection data is shown for the A) Tiano (ANO), B) Horea (HOR) and C) Toamaro (TOA) study sites, as measured by BG trap collections of adult females. Lines show moving averages across four collection periods. Time is shown as the relative week number, with ‘Week 0’ as the start of releases. The grey shaded box indicates the release period on TOA, with CP releases ending on Week 30.
Percent females that produced hatching egg broods at a no-release site (HOR) and the site receiving CP male releases (TOA).
| Field Trial Phase | |||
| Before | During | After | |
|
| 100% | 76%* | 97% |
|
| 98% | 93% | 99% |
The asterisk indicates a significant difference X2 (1, N = 887) = 38.18, p<0.0001.
Figure 2Box plots of delta values used in the BACIPS statistical analysis.
Each of the three possible combinations of site pairs is shown. For each pair, delta values are of collections within the thirty-week period immediately prior to the start of CP male release (‘Before’) and the thirty-week period during CP male release (‘During’). Delta values are calculated as the difference between population numbers at the sites, with population number indicated as ln(Female Number +1). Sites are the release site Toamaro (TOA), which received releases of CP males, and the two no-release sites Tiano (ANO) and Horea (HOR), which did not receive CP male releases. Asterisks indicate a significant difference in comparisons of the ‘Before’ and ‘During’ release periods (p<0.0001).